Access cutting-edge brain cancer treatment through this clinical trial at a research site in Orange. Study-provided care at no cost to qualified participants.
Access brain cancer specialists in Orange at no cost
This study follows strict safety protocols and ethical guidelines
All study-related brain cancer treatment provided free
This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend overall survival and progression-free survival in this population. Eligible participants will have histologically diagnosed H3 K27M-mutant diffuse glioma and have completed standard frontline radiotherapy.
Sponsor: Chimerix
Check if you qualify for this brain cancer clinical trial in Orange, CA
If you're searching for brain cancer treatment options in Orange, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orange research site is actively enrolling participants for this clinical trial. You'll receive care from experienced brain cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.